Antiplatelet therapy in patients undergoing coronary stenting: The risk of late stent thrombosis.

about

Rapid oral desensitisation procedure in clopidogrel hypersensitivity

P2860

Q36465705-F0C0E34A-8903-483A-8279-5244A42CB151

P2860

Antiplatelet therapy in patients undergoing coronary stenting: The risk of late stent thrombosis.

Item

http://www.wikidata.org/entity/Q36917389

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Antiplatelet therapy in patien ...... risk of late stent thrombosis.

@en

type

Item

label

Antiplatelet therapy in patien ...... risk of late stent thrombosis.

@en

prefLabel

Antiplatelet therapy in patien ...... risk of late stent thrombosis.

@en

P1476

Antiplatelet therapy in patien ...... risk of late stent thrombosis.

@en

P2093

A A C M Heestermans

http://www.w3.org/2001/XMLSchema#string

J M Ten Berg

http://www.w3.org/2001/XMLSchema#string

J W van Werkum

http://www.w3.org/2001/XMLSchema#string

M J de Boer

http://www.w3.org/2001/XMLSchema#string

P den Heijer

http://www.w3.org/2001/XMLSchema#string

R M A Hautvast

http://www.w3.org/2001/XMLSchema#string

W Jaarsma

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Late stent thrombosis after implantation of a sirolimus-eluting stent

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

Late thrombosis of sirolimus-eluting stents following noncardiac surgery

Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials

Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

P304

297-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25696663

http://www.w3.org/2001/XMLSchema#string

P921

thrombosis

P932

2557282

http://www.w3.org/2001/XMLSchema#string

Antiplatelet therapy in patients undergoing coronary stenting: The risk of late stent thrombosis.

about

P2860

P2860

Antiplatelet therapy in patients undergoing coronary stenting: The risk of late stent thrombosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932